Abstract
It is well established that matrix metalloproteinases (MMPs) contribute to the degradation of the extracellular matrix of coronary plaque and contribute to the thinning of the fibrous cap. As a result, the atheromatous plaque becomes unstable and prone to rupture with consequent clinical manifestations including acute coronary syndromes. Moreover, genetic polymorphisms of MMPs have been found to be associated with the concentration of circulating MMPs, and over the past decade, considerable efforts have been devoted to explore the relationships between MMPs polymorphisms and myocardial infarction risk among various populations. However, existing studies have yielded inconsistent results. Some observations have suggested that genetic variation that affects the expression of MMPs may contribute to the occurrence of myocardial infarction, whereas others reported no support for an association of MMPs polymorphisms with myocardial infarction susceptibility. Furthermore, the interpretation of these studies has been complicated by the use of different populations or different control sources. Therefore, further studies are required to evaluate the role of matrix metalloproteinases and especially the associated genetic polymorphisms in cardiovascular disease.
Keywords: Matrix metalloproteinases, gene polymorphisms, atherosclerosis, coronary plaque, coronary artery disease, fibrous cap, acute coronary syndromes, myocardial infarction risk, matrix metalloproteinases, genetic polymorphisms, cardiovascular disease, occlusive thrombus, biologic pathway, risk factors
Current Topics in Medicinal Chemistry
Title:Genetic Variability of Matrix Metalloproteinase Genes in Cardiovascular Disease
Volume: 12 Issue: 10
Author(s): Nikolaos Papageorgiou, Dimitris Tousoulis, George Hatzis, Alexandros Briasoulis, Emmanuel Androulakis, Anastasios Giolis, Gerasimos Siasos, George Latsios, Georgia Vogiatzi, Costas Tentolouris and Christodoulos Stefanadis
Affiliation:
Keywords: Matrix metalloproteinases, gene polymorphisms, atherosclerosis, coronary plaque, coronary artery disease, fibrous cap, acute coronary syndromes, myocardial infarction risk, matrix metalloproteinases, genetic polymorphisms, cardiovascular disease, occlusive thrombus, biologic pathway, risk factors
Abstract: It is well established that matrix metalloproteinases (MMPs) contribute to the degradation of the extracellular matrix of coronary plaque and contribute to the thinning of the fibrous cap. As a result, the atheromatous plaque becomes unstable and prone to rupture with consequent clinical manifestations including acute coronary syndromes. Moreover, genetic polymorphisms of MMPs have been found to be associated with the concentration of circulating MMPs, and over the past decade, considerable efforts have been devoted to explore the relationships between MMPs polymorphisms and myocardial infarction risk among various populations. However, existing studies have yielded inconsistent results. Some observations have suggested that genetic variation that affects the expression of MMPs may contribute to the occurrence of myocardial infarction, whereas others reported no support for an association of MMPs polymorphisms with myocardial infarction susceptibility. Furthermore, the interpretation of these studies has been complicated by the use of different populations or different control sources. Therefore, further studies are required to evaluate the role of matrix metalloproteinases and especially the associated genetic polymorphisms in cardiovascular disease.
Export Options
About this article
Cite this article as:
Papageorgiou Nikolaos, Tousoulis Dimitris, Hatzis George, Briasoulis Alexandros, Androulakis Emmanuel, Giolis Anastasios, Siasos Gerasimos, Latsios George, Vogiatzi Georgia, Tentolouris Costas and Stefanadis Christodoulos, Genetic Variability of Matrix Metalloproteinase Genes in Cardiovascular Disease, Current Topics in Medicinal Chemistry 2012; 12 (10) . https://dx.doi.org/10.2174/1568026611208011206
DOI https://dx.doi.org/10.2174/1568026611208011206 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Ca2+-Sensitive K+ Currents in Controlling Ventricular Repolarization: Possible Implications for Future Antiarrhytmic Drug Therapy
Current Medicinal Chemistry Endothelial Dysfunction, Oxidative Stress and Inflammation in Atherosclerosis: Beneficial Effects of Statins
Current Medicinal Chemistry Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics Systemic Hypertension in Patients with Aortic Stenosis: Clinical Implications and Principles of Pharmacological Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial: Paving the Way for Improved Antiplatelet Therapy
Current Pharmaceutical Design Efalizumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Capsaicin Sensitive-Sensory Nerves and Blood Pressure Regulation
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Management of Dyslipidemia in the Metabolic Syndrome
Cardiovascular & Hematological Disorders-Drug Targets Statins and Carotid Intima-Media Thickness Reduction: An Up-to-Date Review
Current Medicinal Chemistry Recent Developments in Phytosterol Recovery from Oil Deodorizer Distillates
Current Nutrition & Food Science Endothelin and the Ischaemic Heart
Current Vascular Pharmacology Radiopharmaceuticals Regulations: Current Scenario and the Way Forward
Applied Clinical Research, Clinical Trials and Regulatory Affairs Probiotics and Oral Health
Current Pharmaceutical Design Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Refined Purification of Large Amounts of Rat cvHsp/HspB7 and Partial Biological Characterization In Vitro
Protein & Peptide Letters Gender Differences in Autonomic Control of the Cardiovascular System
Current Pharmaceutical Design Aesthetic Cardiology: Adipose-Derived Stem Cells for Myocardial Repair
Current Stem Cell Research & Therapy Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
Current Pharmaceutical Design Foreword
Current Pharmaceutical Design Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Current Cardiology Reviews